Saliva point-of-care testing for suboptimal levofloxacin and linezolid exposure in multidrug-resistant tuberculosis.
Saved in:
| Title: | Saliva point-of-care testing for suboptimal levofloxacin and linezolid exposure in multidrug-resistant tuberculosis. |
|---|---|
| Authors: | Nguyen TA; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Department of Pharmacy, Westmead Hospital, Parramatta, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia., Nguyen AT; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Woolcock Institute of Medical Research, Hanoi, Vietnam.; The University of Sydney Vietnam Institute, Ho Chi Minh City, Vietnam., Dinh LV; National Lung Hospital, Hanoi, Vietnam., Nguyen HB; National Lung Hospital, Hanoi, Vietnam., Vu HD; National Drug Information and Adverse Drug Reactions Monitoring Centre, Hanoi University of Pharmacy, Hanoi, Vietnam., Nguyen TNB; Woolcock Institute of Medical Research, Hanoi, Vietnam.; The University of Sydney Vietnam Institute, Ho Chi Minh City, Vietnam., Vu D; Woolcock Institute of Medical Research, Hanoi, Vietnam.; The University of Sydney Vietnam Institute, Ho Chi Minh City, Vietnam., Punt NC; University Medical Centre Groningen, Groningen, The Netherlands.; Medimatics, Maastricht, The Netherlands., Fox GJ; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia.; Royal Prince Alfred Hospital, Camperdown, Australia., Stocker SL; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Department of Pharmacy, Westmead Hospital, Parramatta, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia.; School of Clinical Medicine, The University of New South Wales, Australia.; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Darlinghurst, Australia., Alffenaar JC; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia johannes.alffenaar@sydney.edu.au.; Department of Pharmacy, Westmead Hospital, Parramatta, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia. |
| Source: | The European respiratory journal [Eur Respir J] 2026 Jun 12; Vol. 67 (6). Date of Electronic Publication: 2026 Jun 12 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41571317 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Saliva point-of-care testing for suboptimal levofloxacin and linezolid exposure in multidrug-resistant tuberculosis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nguyen+TA%22">Nguyen TA</searchLink>; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Department of Pharmacy, Westmead Hospital, Parramatta, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia.<br /><searchLink fieldCode="AU" term="%22Nguyen+AT%22">Nguyen AT</searchLink>; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Woolcock Institute of Medical Research, Hanoi, Vietnam.; The University of Sydney Vietnam Institute, Ho Chi Minh City, Vietnam.<br /><searchLink fieldCode="AU" term="%22Dinh+LV%22">Dinh LV</searchLink>; National Lung Hospital, Hanoi, Vietnam.<br /><searchLink fieldCode="AU" term="%22Nguyen+HB%22">Nguyen HB</searchLink>; National Lung Hospital, Hanoi, Vietnam.<br /><searchLink fieldCode="AU" term="%22Vu+HD%22">Vu HD</searchLink>; National Drug Information and Adverse Drug Reactions Monitoring Centre, Hanoi University of Pharmacy, Hanoi, Vietnam.<br /><searchLink fieldCode="AU" term="%22Nguyen+TNB%22">Nguyen TNB</searchLink>; Woolcock Institute of Medical Research, Hanoi, Vietnam.; The University of Sydney Vietnam Institute, Ho Chi Minh City, Vietnam.<br /><searchLink fieldCode="AU" term="%22Vu+D%22">Vu D</searchLink>; Woolcock Institute of Medical Research, Hanoi, Vietnam.; The University of Sydney Vietnam Institute, Ho Chi Minh City, Vietnam.<br /><searchLink fieldCode="AU" term="%22Punt+NC%22">Punt NC</searchLink>; University Medical Centre Groningen, Groningen, The Netherlands.; Medimatics, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Fox+GJ%22">Fox GJ</searchLink>; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia.; Royal Prince Alfred Hospital, Camperdown, Australia.<br /><searchLink fieldCode="AU" term="%22Stocker+SL%22">Stocker SL</searchLink>; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.; Department of Pharmacy, Westmead Hospital, Parramatta, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia.; School of Clinical Medicine, The University of New South Wales, Australia.; Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Darlinghurst, Australia.<br /><searchLink fieldCode="AU" term="%22Alffenaar+JC%22">Alffenaar JC</searchLink>; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia johannes.alffenaar@sydney.edu.au.; Department of Pharmacy, Westmead Hospital, Parramatta, Australia.; Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228803460%22">The European respiratory journal</searchLink> [Eur Respir J] 2026 Jun 12; Vol. 67 (6). <i>Date of Electronic Publication: </i>2026 Jun 12 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22European+Respiratory+Society%22">European Respiratory Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8803460 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1399-3003 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209031936%22">09031936 </searchLink><i>NLM ISO Abbreviation: </i>Eur Respir J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41571317 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1183/13993003.01875-2025 Languages: – Code: eng Text: English Titles: – TitleFull: Saliva point-of-care testing for suboptimal levofloxacin and linezolid exposure in multidrug-resistant tuberculosis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nguyen TA – PersonEntity: Name: NameFull: Nguyen AT – PersonEntity: Name: NameFull: Dinh LV – PersonEntity: Name: NameFull: Nguyen HB – PersonEntity: Name: NameFull: Vu HD – PersonEntity: Name: NameFull: Nguyen TNB – PersonEntity: Name: NameFull: Vu D – PersonEntity: Name: NameFull: Punt NC – PersonEntity: Name: NameFull: Fox GJ – PersonEntity: Name: NameFull: Stocker SL – PersonEntity: Name: NameFull: Alffenaar JC IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 06 Text: 2026 Jun 12 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1399-3003 Numbering: – Type: volume Value: 67 – Type: issue Value: 6 Titles: – TitleFull: The European respiratory journal Type: main |
| ResultId | 1 |
